These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 8097723)
21. Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices. Pizzi M; Da Prada M; Valerio A; Memo M; Spano PF; Haefely WE Brain Res; 1988 Jul; 456(2):235-40. PubMed ID: 2974746 [TBL] [Abstract][Full Text] [Related]
22. Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies. Morissette M; Goulet M; Grondin R; Blanchet P; Bédard PJ; Di Paolo T; Lévesque D Eur J Neurosci; 1998 Aug; 10(8):2565-73. PubMed ID: 9767387 [TBL] [Abstract][Full Text] [Related]
23. Effect of chronic treatment with typical and atypical neuroleptics on the expression of dopamine D2 and D3 receptors in rat brain. Hurley MJ; Stubbs CM; Jenner P; Marsden CD Psychopharmacology (Berl); 1996 Dec; 128(4):362-70. PubMed ID: 8986007 [TBL] [Abstract][Full Text] [Related]
24. Differential pharmacological profile of striatal and cerebellar dopamine receptors labeled by [3H]quinpirole: identification of a discrete population of putative D3 receptors. Levant B; DeSouza EB Synapse; 1993 May; 14(1):90-5. PubMed ID: 8099762 [TBL] [Abstract][Full Text] [Related]
25. Postnatal lead exposure induces supersensitivity to the stimulus properties of a D2-D3 agonist. Cory-Slechta DA; Pokora MJ; Widzowski DV Brain Res; 1992 Dec; 598(1-2):162-72. PubMed ID: 1362517 [TBL] [Abstract][Full Text] [Related]
26. Visualization of dopamine D3-like receptors in human brain with [125I]epidepride. Murray AM; Ryoo H; Joyce JN Eur J Pharmacol; 1992 Dec; 227(4):443-5. PubMed ID: 1359976 [TBL] [Abstract][Full Text] [Related]
27. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding. Engber TM; Marin C; Susel Z; Chase TN Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970 [TBL] [Abstract][Full Text] [Related]
28. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185 [TBL] [Abstract][Full Text] [Related]
29. Modulation of dopamine D3 receptor binding by N-ethylmaleimide and neurotensin. Liu Y; Hillefors-Berglund M; von Euler G Brain Res; 1994 Apr; 643(1-2):343-8. PubMed ID: 7913398 [TBL] [Abstract][Full Text] [Related]
30. Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats. Yamada S; Yokoo H; Nishi S Brain Res; 1994 Jun; 648(1):176-9. PubMed ID: 7922522 [TBL] [Abstract][Full Text] [Related]
31. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour. Koshikawa N; Kitamura M; Kobayashi M; Cools AR Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293 [TBL] [Abstract][Full Text] [Related]
32. Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors. Fuxe K; Fredholm BB; Agnati LF; Corrodi H Brain Res; 1978 May; 146(2):295-311. PubMed ID: 647392 [TBL] [Abstract][Full Text] [Related]
33. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain. Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z Eur J Pharmacol; 1998 Jun; 351(1):31-7. PubMed ID: 9698202 [TBL] [Abstract][Full Text] [Related]
34. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181 [TBL] [Abstract][Full Text] [Related]
35. Effect of the dopamine D2 receptor agonist quinpirole on the in vivo release of dopamine in the caudate nucleus of hypertensive rats. Linthorst AC; De Lang H; De Jong W; Versteeg DH Eur J Pharmacol; 1991 Aug; 201(2-3):125-33. PubMed ID: 1686754 [TBL] [Abstract][Full Text] [Related]
36. Anticonvulsant effects of ipsilateral but not contralateral microinjections of the dopamine D2 agonist LY 171555 into the nucleus accumbens of amygdala-kindled rats. Wahnschaffe U; Löscher W Brain Res; 1991 Jul; 553(2):181-7. PubMed ID: 1681980 [TBL] [Abstract][Full Text] [Related]
37. Antagonism of quinpirole by (+)-AJ 76: possible involvement of D3 receptors. Gui-Hua C; Woolverton WL Eur J Pharmacol; 1991 Dec; 209(3):285-6. PubMed ID: 1686769 [No Abstract] [Full Text] [Related]
38. Autoradiographic evidence for the occlusion of rat brain dopamine D3 receptors in vivo. Schotte A; Janssen PF; Gommeren W; Luyten WH; Leysen JE Eur J Pharmacol; 1992 Aug; 218(2-3):373-5. PubMed ID: 1425949 [TBL] [Abstract][Full Text] [Related]
39. Up-regulation of D3 dopamine receptor mRNA by neuroleptics. Wang W; Hahn KH; Bishop JF; Gao DQ; Jose PA; Mouradian MM Synapse; 1996 Jul; 23(3):232-5. PubMed ID: 8807752 [TBL] [Abstract][Full Text] [Related]
40. Involvement of adenylate cyclase inhibition in dopamine autoreceptor regulation of tyrosine hydroxylase in rat nucleus accumbens. Onali P; Olianas MC Neurosci Lett; 1989 Jul; 102(1):91-6. PubMed ID: 2571111 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]